Delix Therapeutics

Delix Therapeutics

Biotechnology Research

Boston, Massachusetts 7,128 followers

Repairing the Brain to Heal the Mind

About us

Delix Therapeutics is applying modern tools of pharmaceutical development to some of nature's most ancient therapies, psychedelics. Through its discovery platform, Delix has identified a new class of non-hallucinogenic versions of psychedelic compounds with favorable safety and therapeutic profiles. Delix is rapidly advancing these psychoplastogen compounds through preclinical and clinical development, with the goal of one day alleviating mental suffering through its FDA-approved, take-home medicines.

Industry
Biotechnology Research
Company size
11-50 employees
Headquarters
Boston, Massachusetts
Type
Privately Held
Founded
2019

Locations

Employees at Delix Therapeutics

Updates

Similar pages

Browse jobs

Funding

Delix Therapeutics 7 total rounds

Last Round

Grant

US$ 825.0K

See more info on crunchbase